Jason Thomas
AHN Cancer Institute-Med Onc & Infusions at Forbes, Suite 2A
Office (412) 373-4411
Fax (412) 373-4677
2626 Haymaker Road,
Second Floor
Monroeville, PA 15146
About
Jason Thomas
Jason Thomas practices as an Oncologist in Monroeville, PA.He graduated from University of Medicine and Dentistry of New Jersey.
Primary Specialty
Oncologist
Practice
AHN Cancer Institute-Med Onc & Infusions at Forbes, Suite 2A
Gender
Male
Education
University of Medicine and Dentistry of New Jersey
Training
UPMCUniversity of Pittsburgh Medical Center, The Ohio State University Wexner Medical Center
Certification
American Board of Internal Medicine-Medical Oncology
Not Accepting New Patients
Degrees
Medical Doctor
Admitting Hospitals
Allegheny General Hospital, Allegheny Valley Hospital, Canonsburg Hospital, West Penn Hospital, Jefferson Hospital, Forbes Hospital
Office Name
AHN Cancer Institute-Med Onc & Infusions at Forbes, Suite 2A
Languages
English
Business Hours
Monday:9:00 AM - 4:00 PM
Tuesday:9:00 AM - 4:00 PM
Wednesday:9:00 AM - 4:00 PM
Thursday:9:00 AM - 4:00 PM
Friday:9:00 AM - 4:00 PM
Saturday:Closed
Sunday:Closed
Services
neuroendocrine carcinoma, neuroendocrine tumor of the lung, adenocarcinoma of the bladder, clinical trials, coagulation disorders, hodgkin lymphoma, prostate cancer, von willebrand disease, adenocarcinoma of lung, non hodgkin lymphoma, factor v leiden, thyroid cancer, thrombocytopenia, stomach cancer, small cell lung cancer, sarcoma, kidney cancer, pulmonary metastases, pancreas cancer, non small cell lung cancer, multiple myeloma, gallbladder cancer, lung cancer, liver cancer, large cell cancer of the lung, iron deficiency anemia, hypercoagulable state, carcinoid tumor, cancer chemotherapy, cancer, blood clotting disorder, anemia, chemotherapy iv infusion, rectal neuroendocrine tumor, metastatic neuroendocrine tumors, relapsed myeloma, colon adenocarcinoma, neutrophilia, elevated transferrin saturation, elevated ferritin, large cell neuroendocrine tumors, metastatic blood cancers, generalized lymphatic anomaly, fibrolamellar carcinoma, personal history of cancer, secondary cancer screening, blood cancer chemotherapy, autoimmune neutropenia (ain), evans syndrome, hemophilia inhibitors, factor thirteen deficiency, factor seven deficiency, hereditary elliptocytosis (he), acquired elliptocytosis, prostate cancer chemotherapy, bladder cancer chemotherapy, testicular cancer chemotherapy, relapsed acute myelogenous leukemia (aml), relapsed non hodgkin lymphoma, relapsed hodgkin lymphoma, relapsed acute lymphoblastic leukemia (all), neutrophil disorders, blastic plasmacytoid dendritic cell neoplasm, disseminated intravascular coagulation, carcinoma of unknown primary, lymphomatoid granulomatosis, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, pituitary cancer, chronic myelomonocytic leukemia, malignant adnexal tumor, peripheral t cell lymphoma, intraarterial chemotherapy of tumors, brain metastases, bone marrow failure syndromes, waldenstrom macroglobulinemia, liver metastases, adrenal nodules, cancer genetics, hemoglobinopathies, thrombocytosis, acute blood loss anemia, blood disorders, lymphopenia, early detection of cancer, acute myelogenous leukemia (aml), acute lymphoblastic leukemia (all), abdominal chemotherapy, multiple endocrine neoplasia type 2b, multiple endocrine neoplasia type 2a, multiple endocrine neoplasia type 2, multiple endocrine neoplasia type 1, papillary cancer of thyroid, medullary cancer of thyroid, follicular cancer of thyroid, poems syndrome, squamous cancer of the lung, esophageal cancer